Categories
Diagnosis of Circulatory Encephalopathy and Biophilia Tracker
We can use the Tracker system with a 4.9 GHz generator frequency and the Biophilia Tracker software to diagnose DE.
Dec 27th,2025
110 Views
Recently, chronic forms of cerebrovascular disease have become increasingly important in the structure of cerebrovascular disorders. Among them, circulatory encephalopathy (DE) accounts for the largest proportion. The clinical manifestations of this disease are well studied, but simultaneously, from a case-medical perspective, the identification of structural changes in brain detection, clinical and instrumental similarities, and the early definition of optimal treatment strategies are becoming increasingly urgent.We can use the Tracker system with a 4.9 GHz generator frequency and the Biophilia Tracker software to diagnose DE.The clinical manifestations of DE have a progressive process. NLS-research analysis confirms that in the first stage of the disease, there are no characteristic changes in the brain, and no obvious neurological syndromes develop; subjective impairment, accompanied by mild neurosymptoms, is dominant. The second stage of DE allows us to identify certain prevalent neurological syndromes—incoordination, pyramidal and dystonia, manifested as single or multiple gliomas without a tendency to co-occur, which is a significant reason for the reduction in patients' professional and social adaptation. Based on data from NLS-research and REA, in stage III of DE, the number of complaints decreases significantly, but neurological disorders become more prominent, presenting as very obvious and significant neurological syndromes combined with marked brain structural changes.Therefore, as DE progresses, structural changes in brain tissue become more frequent: the frequency and extent of atrophy increase, and single cystic nesting changes in the brain become multiple.The diagnosis of DE is complex, involving methods of neurovisualization, and we believe one of the most informative and prospective methods is NLS imaging with REA. Detecting and evaluating nesting and diffuse NLS changes in brain tissue within the context of clinical and subclinical neurological and neuropsychological data creates conditions for early diagnosis of progressive forms of DE and for targeted, aggressive treatment to prevent further brain damage.
